Getinge Group

1
Getinge Group
2
Shaping Health Care of tomorrow
3
Shaping Health Care of tomorrow
4
Infection Control- Fact sheet 2004 numbers
Revenues 3,524 MSEKEBITA margin 15.2
5
Extended Care Fact sheet 2004 Numbers
Revenues 2,701 MSEKEBITA margin 18.9
6
Medical Systems Fact sheet 2004 Numbers
Revenues 4,620 MSEKEBITA margin 15.4
7
Getinge Group Development
8
(No Transcript)
9
Our customers in the healthcare industry respond
to the changes by
Financial Targets

• Health care policy makers will increasingly look
  for privatisation and market testing as tools to
  achieve cost efficiency
• Activity based reimbursements continue to drive
  process efficiency
• Focus on core competencies in medical processes
• Elective care will be provided in outpatient
  facilities

10
Positive Outcomes
A competent solution provider in well defined
niches of the health care industry offering
solutions that enhance customers productivity
over time
11
Strategic Cornerstones

• Global leadership

12
Global leadership
We strive to be a global No 1 or No 2 in the
product areas focused.Market leadership will
help us attain cost leadership through scale
13
Strategic Cornerstones

• Global leadership
• Innovative solutions

14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
Results 1993 - 2004
20
(No Transcript)
21
2004 Financials
22
Getinge AB - Financials (MSEK)
2004 2003 Change 2004 2003 Change
  Q 4 Q 4   12 Mon 12 Mon  
Orders received 2,981 2,675 11 10,812 9,154 18

Net sales 3,477 2,929 19 10,889 9,160 19
EBITA 682 544 25 1,757 1,449 21
EBITA 19.6 18.6 16.1 15.8
EBIT 621 477 30 1,505 1,257 20
EBIT 17.9 16.3 13.8 13.7
Profit before tax 574 432 33 1,309 1,095 20
23
Getinge AB - Key figures (MSEK)
2004 2003 2004 2003
  Q 4 Q 4 12 Mon 12 Mon

Operating Cash Flow, MSEK 584 556 1,878 1,980

Net debt, MSEK 4,705 4,852

Equity / Assets ratio, 33.1 29.3

Net debt / Equity ratio, multiple 1.18 1.37

Interest cover, multiple 7.1 7.3
24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
(No Transcript)